BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32729074)

  • 21. Induction of cytidine to uridine editing on cytoplasmic apolipoprotein B mRNA by overexpressing APOBEC-1.
    Yang Y; Sowden MP; Smith HC
    J Biol Chem; 2000 Jul; 275(30):22663-9. PubMed ID: 10833526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RNA editing of BFP, a point mutant of GFP, using artificial APOBEC1 deaminase to restore the genetic code.
    Bhakta S; Sakari M; Tsukahara T
    Sci Rep; 2020 Oct; 10(1):17304. PubMed ID: 33057101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The apolipoprotein B mRNA editing complex performs a multifunctional cycle and suppresses nonsense-mediated decay.
    Chester A; Somasekaram A; Tzimina M; Jarmuz A; Gisbourne J; O'Keefe R; Scott J; Navaratnam N
    EMBO J; 2003 Aug; 22(15):3971-82. PubMed ID: 12881431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The RNA editing enzyme APOBEC1 induces somatic mutations and a compatible mutational signature is present in esophageal adenocarcinomas.
    Saraconi G; Severi F; Sala C; Mattiuz G; Conticello SG
    Genome Biol; 2014 Jul; 15(7):417. PubMed ID: 25085003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The genetic basis for individual differences in mRNA splicing and APOBEC1 editing activity in murine macrophages.
    Hassan MA; Butty V; Jensen KD; Saeij JP
    Genome Res; 2014 Mar; 24(3):377-89. PubMed ID: 24249727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C-to-U editing and site-directed RNA editing for the correction of genetic mutations.
    Vu LT; Tsukahara T
    Biosci Trends; 2017 Jul; 11(3):243-253. PubMed ID: 28484188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors.
    Grünewald J; Zhou R; Garcia SP; Iyer S; Lareau CA; Aryee MJ; Joung JK
    Nature; 2019 May; 569(7756):433-437. PubMed ID: 30995674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Base editing with a Cpf1-cytidine deaminase fusion.
    Li X; Wang Y; Liu Y; Yang B; Wang X; Wei J; Lu Z; Zhang Y; Wu J; Huang X; Yang L; Chen J
    Nat Biotechnol; 2018 Apr; 36(4):324-327. PubMed ID: 29553573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measuring editing activity and identifying cytidine-to-uridine mRNA editing factors in cells and biochemical isolates.
    Smith HC
    Methods Enzymol; 2007; 424():389-416. PubMed ID: 17662851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycosylase base editors enable C-to-A and C-to-G base changes.
    Zhao D; Li J; Li S; Xin X; Hu M; Price MA; Rosser SJ; Bi C; Zhang X
    Nat Biotechnol; 2021 Jan; 39(1):35-40. PubMed ID: 32690970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epitranscriptomic profiling across cell types reveals associations between APOBEC1-mediated RNA editing, gene expression outcomes, and cellular function.
    Rayon-Estrada V; Harjanto D; Hamilton CE; Berchiche YA; Gantman EC; Sakmar TP; Bulloch K; Gagnidze K; Harroch S; McEwen BS; Papavasiliou FN
    Proc Natl Acad Sci U S A; 2017 Dec; 114(50):13296-13301. PubMed ID: 29167373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An overview of cytidine deaminases.
    Navaratnam N; Sarwar R
    Int J Hematol; 2006 Apr; 83(3):195-200. PubMed ID: 16720547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Substitutional RNA Editing in Plant Organelles.
    Ichinose M; Sugita M
    Methods Mol Biol; 2021; 2181():1-12. PubMed ID: 32729071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RNA editing: cytidine to uridine conversion in apolipoprotein B mRNA.
    Chester A; Scott J; Anant S; Navaratnam N
    Biochim Biophys Acta; 2000 Nov; 1494(1-2):1-13. PubMed ID: 11072063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutational analysis of apolipoprotein B mRNA editing enzyme (APOBEC1). structure-function relationships of RNA editing and dimerization.
    Teng BB; Ochsner S; Zhang Q; Soman KV; Lau PP; Chan L
    J Lipid Res; 1999 Apr; 40(4):623-35. PubMed ID: 10191286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. APOBEC1 mediated C-to-U RNA editing: target sequence and trans-acting factor contribution to 177 RNA editing events in 119 murine transcripts in-vivo.
    Soleymanjahi S; Blanc V; Davidson N
    RNA; 2021 Jun; 27(8):876-90. PubMed ID: 34083494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNA binding to APOBEC deaminases; Not simply a substrate for C to U editing.
    Smith HC
    RNA Biol; 2017 Sep; 14(9):1153-1165. PubMed ID: 27869537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. APOBEC4, a new member of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases predicted by computational analysis.
    Rogozin IB; Basu MK; Jordan IK; Pavlov YI; Koonin EV
    Cell Cycle; 2005 Sep; 4(9):1281-5. PubMed ID: 16082223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carboxy-terminal domain of AID required for its mRNA complex formation in vivo.
    Nonaka T; Doi T; Toyoshima T; Muramatsu M; Honjo T; Kinoshita K
    Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2747-51. PubMed ID: 19196959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of APOBEC1 RNA-editing function in microglia exacerbates age-related CNS pathophysiology.
    Cole DC; Chung Y; Gagnidze K; Hajdarovic KH; Rayon-Estrada V; Harjanto D; Bigio B; Gal-Toth J; Milner TA; McEwen BS; Papavasiliou FN; Bulloch K
    Proc Natl Acad Sci U S A; 2017 Dec; 114(50):13272-13277. PubMed ID: 29167375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.